Selective reduction of serotonin storage and ATP release in chronic renal failure patients platelets

American Journal of Hematology
G SoslauA B Schwartz

Abstract

Hemorrhagic complications, as monitored by skin bleeding times, occur in a significant number of chronic renal failure (CRF) patients. The etiology of hemostatic defects in these patients is complex and ill defined. Our studies demonstrate, for the first time, that activated platelets, derived from CRF patients, release significantly (P less than .001) less ATP than controls while the percent of releasable serotonin (5HT), assumed to be co-stored with ATP, is unaltered. Analysis of the CRF-derived platelets reflects a selective acquired storage pool defect with significantly (P less than .001) reduced 5HT levels while their dense granule contents of ATP and ADP are normal. The comparison of ATP release from platelets derived from CRF patients whose bleeding times were less than 9 min to those with bleeding times of 9 min or greater was significantly different (P less than .02). This report demonstrates for the first time that there is a statistically significant correlation of ATP release and 5HT content to bleeding times (P less than .001). The perturbation of platelet 5HT uptake, 5HT dense granule content, and ATP release appears to result from newly described altered plasma factors, detected by our in vitro mixing studies. I...Continue Reading

References

Jan 1, 1992·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J U Leititis, M Brandis
Jan 1, 1993·International Journal of Clinical & Laboratory Research·J MalyszkoW Buczko
Jul 15, 1996·Thrombosis Research·D PawlakM Mysliwiec
Sep 1, 1996·Thrombosis Research·J MalyszkoM Mysliwiec
Mar 12, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Olivier MorelThierry Hannedouche
Feb 1, 1994·The American Journal of Medicine·M E Eberst, L R Berkowitz
Oct 27, 2004·The Veterinary Journal·R Mischke, U Schulze
Apr 8, 2014·Journal of Interventional Cardiology·Claudio MorettiFiorenzo Gaita
Jun 14, 2018·Clinical Cardiology·Nader Makki, Scott M Lilly
Jun 18, 2015·Journal of the American Heart Association·Tanush GuptaJulio A Panza
Oct 1, 1991·American Journal of Hematology·G SoslauI Brodsky

Citations

Feb 15, 1988·Biochemical and Biophysical Research Communications·G SoslauJ Parker
Jan 15, 1986·The Biochemical Journal·J L Gordon
Nov 1, 1985·The American Journal of Medicine·G Di MinnoS Murphy
Mar 27, 1969·The New England Journal of Medicine·G EknoyanJ J Will
Oct 1, 1982·European Journal of Clinical Investigation·J Vlachoyannis, W Schoeppe
Mar 1, 1983·The Journal of Clinical Investigation·G RemuzziC Patrono

Related Concepts

Serotonin Measurement
Serotonin
Vascular Hemostatic Disorders
Thyroid Hormone Plasma Membrane Transport Defect
Hemostatic Agents
Blood Coagulation Disorders
5-hydroxytryptamine Uptake
Etiology
Renal Insufficiency
Platelet Aggregation

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.